5-HT1A receptors and memory

Neuroscience and Biobehavioral Reviews

Volumn 31, Issue 5, 2007, Pages 705-727

  Meneses, Alfredo ^a   Perez Garcia, Georgina ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT receptors; Animals; Consolidation; Human; Memory

Indexed keywords

1 (1,4 BENZODIOXAN 5 YL) 4 (2 INDANYL)PIPERAZINE; 1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 CT; 8 [2 [(2,3 DIHYDRO 1,4 BENZODIOXIN 2 YL)METHYLAMINO]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALNESPIRONE; AMISULPRIDE; BUSPIRONE; CLOZAPINE; DIAZEPAM; FENCLONINE; FLESINOXAN; FLUOXETINE; HISTIDINE; HYPERICUM PERFORATUM EXTRACT; IPSAPIRONE; LECOZOTAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; POSTSYNAPTIC RECEPTOR; PROPRANOLOL DERIVATIVE; PSILOCYBINE; ROBALZOTAN; SCOPOLAMINE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR; SPIPERONE; TANDOSPIRONE; TERTATOLOL; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMNESIA; BEHAVIOR; BINDING AFFINITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; LEARNING; MEMORY; MEMORY CONSOLIDATION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALS; HUMANS; MEMORY; RECEPTOR, SEROTONIN, 5-HT1A;

EID: 34247563803     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2007.02.001     Document Type: Review

References (178)

1. Ahlenius S., Larsson K., and Wijkstrom A. Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat. European Journal of Pharmacology 200 (1991) 259-266
2. Altman H.J., and Normile H.J. What is the nature of the role of the serotonergic nervous system in learning and memory?: prospects for development of an effective treatment strategy for senile dementia. Neurobiology of Aging 9 (1988) 627-638
3. Araki T., Yamasue H., Sumiyoshi T., Kuwabara H., Suga M., Iwanami A., Kato N., and Kasai K. Perospirone in the treatment of schizophrenia: effect on verbal memory organization. Progress in Neuro-Psychopharmacology & Biological Psychiatry 30 (2006) 204-208
4. Ardenghi P., Barros D., Izquierdo L.A., Bevilaqua L., Schroder N., Quevedo J., Rodrigues C., Madruga M., Medina J.H., and Izquierdo I. Late and prolonged post-training memory modulation in entorhinal and parietal cortex by drugs acting on the cAMP/protein kinase. A signaling pathway. Behavioural Pharmacology 8 (1997) 745-751
5. Arvidsson L.E., Hacksell U., Johansson A.M., Nilsson J.L., Lindberg P., Sanchez D., Wikstrom H., Svensson K., Hjorth S., and Carlsson A. 8-hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Journal of Medicinal Chemistry 27 1 (1984) 45-51
6. Balducci C., Nurra M., Pietropoli A., Samanin R., and Carli M. Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635. Psychopharmacology (Berlin) 167 (2003) 28-36
7. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 (1999) 1083-1152 (Review)
8. 1, β-noradrenergic, serotonergic-1A and cholinergic muscarinic receptors in cortical structures of the rat. Behavioural Brain Research 124 (2001) 1-7
9. Bartolomeo A.C., Morris H., Moyer J.A., and Boast C.A. Attenuated MK-801-induced impairment of radial maze performance in rats. A possible model predicting efficacy in Alzheimer's disease. Society of Neurosciences Abstract 22 (1996) 43
10. Baumgarten H.G., and Göthert M. Serotonergic Neurons and 5-HT Receptors in the CNS (2000), Springer, Germany 767p
11. 1A receptor impairs water-maze but not hole-board performance. Neurobiology of Learning and Memory 84 (2005) 57-68
12. 1A receptor in dentate gyrus and cortex. Journal of Pharmacology Science Suppl 1 (2006) 101-111
13. 1A receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT. Behavioural Brain Research 167 (2006) 328-341
14. Bertrand F., Lehmann O., Lazarus C., Jeltsch H., and Cassel J.C. Intraseptal infusions of 8-OH-DPAT in the rat impairs water-maze performances: effects on memory or anxiety?. Neuroscience Letters 279 (2000) 45-48
15. Bertrand F., Lehmann O., Galani R., Lazarus C., Jeltsch H., and Cassel J.C. Effects of MDL 73005 on water-maze performances and locomotor activity in scopolamine-treated rats. Pharmacology Biochemistry and Behavior 68 (2001) 647-660
16. Blair C.A.J., Bonardi C., and Hall G. Differential effects of 8-OH-DPAT on two forms of appetitive Pavlovian conditioning in the rat. Behavioral Neuroscience 118 (2004) 1439-1443
17. Bonaventure P., Nepomuceno D., Kwok A., Chai W., Langlois X., Hen R., Stark K., Carruthers N., and Lovenberg T.W. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H] 8-hydroxy-2-(di-n-propylamino) tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. Journal of Pharmacology and Experimental Therapeutics 302 (2002) 240-248
18. Borelli K.G., Gargaro A.C., dos Santos J.M., and Brandao M.L. Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning. Neuroscience Letters 387 (2005) 105-110
19. Borg J., Andrée B., Lundberg J., Halldin C., and Farde L. Search for correlations between serotonin 5-HT1A receptor expression and cognitive functions-a strategy in translational. Psychopharmacology 185 (2006) 389-394
20. Buhot M.C. Serotonin receptors in cognitive behaviors. Current Opinion in Neurobiology 7 (1997) 243-254
21. Buhot M.C., Wolff M., and Segu L. Serotonin. In: Gernot R., and Bettina P. (Eds). Memories are Made of These: From Messengers to Molecules (2003), Eurekah.com and Kluwer Academic/Plenum Publishers 1-19
22. 1A. British Journal of Pharmacology 105 (1992) 720-726
23. Carli M., and Samanin R. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors. Psychopharmacology (Berlin) 149 (2000) 259-268
24. 1A receptors in the hippocampus. Behavioural Brain Research 67 (1995) 67-74
25. Carli M., Bonalumi P., and Samanin R. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. Brain Research 774 (1997) 167-174
26. 1A receptors in the dorsal raphe reverses the impairment caused by intrahippocampal scopolamine in rats. European Journal of Neuroscience 10 (1998) 221-230
27. Carli M., Silva S., Balducci C., and Samanin R. WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors. Neuropharmacology 38 (1999) 1165-1173
28. Carli M., Balducci C., Millan M.J., Bonalumi P., and Samanin R. S 15535, a benzodioxopiperazine acting as presynaptic agonist and postsynaptic 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine. British Journal of Pharmacology 128 (1999) 1207-1214
29. 1A receptors in the dorsal raphe ameliorates the impairment of spatial learning caused by intrahippocampal 7-chloro-kynurenic acid in naive and pretrained rats. Psychopharmacology (Berlin) 158 (2001) 39-47
30. Carli M., Baviera M., Invernizzi R.W., and Balducci C. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 31 (2006) 757-767
31. Carter O.L., Pettigrew J.D., Hasler F., Wallis G.M., Liu G.B., Hell D., and Vollenweider F.X. Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Neuropsychopharmacology 30 (2005) 1154-1162
32. Carter O.L., Burr D.C., Pettigrew J.D., Wallis G.M., Hasler F., and Vollenweider F.X. Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. Journal of Cognitive Neuroscience 17 (2005) 1497-1508
33. Cassel J.C., and Jeltsch H. Serotonergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience 69 (1995) 1-41
34. Ciranna L. Serotonin as a modulator of glutamate- and GABA-mediated neurotransmission: implications in physiological functions and in pathology. Current Neuropharmacology 4 (2006)
35. 1A receptor agonists improve the performance of normal and scopolamine-impaired rats in an operant delayed matching to position task. Psychopharmacology 116 (1994) 135-142
36. Davis H.P., and Squire L.R. Protein synthesis and memory: a review. Psychological Bulletin 96 (1984) 518-559
37. 1A antagonist. British Journal of Pharmacology 115 (1995) 1169-1174
38. Dukic S., Kostic-Rajacic S., Dragovic D., Soskic V., and Joksimovic J. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands. Journal of Pharmacy and Pharmacology 49 (1997) 1036-1041
39. 1A receptors in the dorsal hippocampus. Brain Research 1069 (2006) 54-62
40. 1A/7 receptor agonist 8-OH-DPAT. Neuroscience Letters 404 (2006) 122-126
41. Fernández-Pérez S., Pache D.M., and Sewell R.D.E. Co-administration of fluoxetine and WAY100635 improves short-term memory function. European Journal of Pharmacology 522 (2005) 78-83
42. Fletcher A., Bill D.J., Bill S.J., Cliffe I.A., Dover G.M., Forster E.A., Haskins J.T., Jones D., Mansell H.L., and Reilly Y. WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. European Journal of Pharmacology 237 (1993) 283-291
43. 6 compounds as a novel approach to the treatment of Alzheimer's disease. Journal of Pharmacology Science 101 (2006) 53
44. Francis P.T., Pangalos M.N., and Bowen D.M. Animal and drug modelling for Alzheimer synaptic pathology. Progress in Neurobiology 39 (1992) 517-545
45. 1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin, in rats. Research Communication Chemistry Pathology Pharmacology 58 (1987) 409-412
46. Galeotti N., Ghelardini C., and Bartolini A. Role of 5-HT1A receptors in a mouse passive avoidance paradigm. Japanese Journal of Pharmacology 84 (2000) 418-424
47. 6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease. Neuropsychopharmacology 29 (2004) 410-416
48. Garcia-Alloza M., Gil-Bea F.J., Diez-Ariza M., Chen C.P., Francis P.T., Lasheras B., and Ramirez M.J. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 43 (2005) 442-449
49. Garoflos E., Panagiotaropoulos T., Pondiki S., Stamatakis A., Philippidis E., and Stylianopoulou F. Cellular mechanisms underlying the effects of an early experience on cognitive abilities and affective states. Annual General Psychiatry 6 (2005) 4-8
50. Green A.R. Neuropharmacology of 5-hydroxytryptamine. British Journal of Pharmacology 147 (2006) 145-152
51. 1A receptor inverse agonist SL88.0338-08. Society of Neuroscience Abstract 24 (1998) 1363
52. Hamik A., Oksenberg D., Fischette C., and Peroutka S.J. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites. Biological Psychiatry 28 (1990) 99-109
53. 1A antagonist, WAY100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset. Psychopharmacology 127 (1996) 245-254
54. Harvey J.A. Serotonergic regulation of associate learning. Behavioural Brain Research 73 (1996) 47-50
55. 1A/2A receptor changes evoked by a time-dependent sensitization (TDS) stress model in rats. Brain Research 983 (2003) 97-107
56. 7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation. Pain 113 (2005) 405-415
57. Helsley S., Siegel T.L., Fiorella D., Rabin R.A., and Winter J.C. WAY-100635 reverses 8-OH-DPAT-induced performance impairment in the radial maze. Progress in Neuro-Psychopharmacology & Biological Psychiatry 22 (1998) 1179-1184
58. Hensler J.G. Serotonergic modulation of the limbic system. Neuroscience and Biobehavioral Reviews 30 (2006) 303-314
59. Hjorth S., and Carlsson A. Buspirone: effects on central monoaminergic transmission-possible relevance to animal experimental and clinical findings. European Journal of Pharmacology 83 3-4 (1982) 299-303
60. Hjorth S., Carlsson A., Lindberg P., Sanchez D., Wikström H., Hacksell U., and Nilsson J.L.G. 8-Hydroxy-2-(di-n-p ropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of Medicinal Chemistry 24 (1981) 921-923
61. 3 antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. Psychopharmacology 125 (1996) 146-161
62. Hoyer D., Hartig P.R., and Humphrey P.P.A. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacological Reviews 46 (1994) 157-203
63. Hoyer D., Hannon J.P., and Martin G.R. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacology Biochemistry and Behavior 71 (2002) 533-554 (Review)
64. 1A Receptors (1987), Ellis Horwood Ltd., Chichester, England 278-285
65. Inui K., Egashira N., Mishima K., Yano A., Matsumoto Y., Hasebe N., Abe K., Hayakawa K., Ikeda T., Iwasaki K., and Fujiwara M. The serotonin1A receptor agonist 8-OHDPAT reverses delta 9-tetrahydrocannabinol-induced impairment of spatial memory and reduction of acetylcholine release in the dorsal hippocampus in rats. Neurotoxicology Research 6 (2004) 153-158
66. Isayama S., Sugimoto Y., Nishiga M., and Kamei C. Effects of Histidine on Working Memory Deficits Induced by the 5-HT1A Receptor-Agonist 8-OH-DPAT. Japanese Journal of Pharmacology 86 (2001) 451-453
67. Izquierdo I., Medina J.H., Izquierdo L.A., Barros D.M., Desouza M.M., and Souza T.M.E. Short- and long-term memory are differentially regulated by monoaminergic systems in the rat brain. Neurobiology of Learning and Memory 63 (1998) 219-224
68. Izquierdo I., Medina J.H., Vianna M.R., Izquierdo L.A., and Barros D.M. Separate mechanisms for short- and long-term memory. Behavioural Brain Research 103 (1999) 1-11
69. Izquierdo I., Bevilaqua L.R., Rossato J.I., Bonini J.S., Medina J.H., and Cammarota M. Different molecular cascades in different sites of the brain control memory consolidation. Trends in Neuroscience 29 (2006) 496-505
70. Jacobs B.L., and Azmitia E.C. Structure and function of the brain serotonin system. Physiological Reviews 72 (1992) 165-229
71. Jeltsch H., Bertrand F., Galani R., Lazarus C., Schimchowitsch S., and Cassel J.C. Intraseptal injection of the 5-HT1A/5-HT7 agonist 8-OH-DPAT and working memory in rats. Psychopharmacology (Berlin) 175 (2004) 37-46
72. Johansson L., Sohn D., Thorberg S.O., Jackson D.M., Kelder D., Larsson L.G., Renyi L., Ross S.B., Wallsten C., Eriksson H., Hu P.S., Jerning E., Mohell N., and Westlind-Danielsson A. The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299. Journal of Pharmacology and Experimental Therapeutics 283 (1997) 216-225
73. Kepe V., Barrio J.R., Huang S.C., Ercoli L., Siddarth P., Shoghi-Jadid K., Cole G.M., Satyamurthy N., Cummings J.L., Small G.W., and Phelps M.E. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proceedings of the National Academy of Sciences of the United States of America 103 (2006) 702-707
74. 1A receptors are expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca-a double immunocytochemical study. Neurosciences 74 (1996) 143-154
75. Kidd E.J., Haj-Dahmane S., Jolas T., Lanfumey L., Fattaccini C.M., Guardiola-Lemaitre B., Gozlan H., and Hamon M. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(±)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors. Journal of Pharmacology and Experimental Therapeutics 264 (1993) 863-872
76. Khalifa A.E. Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. Journal of Ethnopharmacology 76 (2001) 49-57
77. Klemenhagen K.C., Gordon J.A., David D.J., Hen R., and Gross C.T. Increased fear response to contextual cues in mice lacking the 5-HT1A receptor. Neuropsychopharmacology 31 (2006) 101-111
78. Kroeze W.K., and Roth B.L. The molecular biology of serotonin receptors: therapeutic implications for the interface of mood and psychosis. Biological Psychiatry 44 (1998) 1128-1142
79. Kushwaha N., Harwood S.C., Wilson A.M., Berger M., Tecott L.H., Roth B.L., and Albert P.R. Molecular determinants in the second intracellular loop of the 5-hydroxytryptamine-1A receptor for G-protein coupling. Molecular Pharmacology 69 (2006) 1518-1526
80. 1 receptors. Current Drug Targets-CNS Neurology Disorders 3 (2004) 1-10
81. Levkovitz Y., Ophir-Shaham O., Bloch Y., Treves I., Fennig S., and Grauer E. Effect of l-tryptophan on memory in patients with schizophrenia. Journal of Nervous and Mental Disease 191 (2003) 568-573
82. Liang K.C. Pre- or post-training injection of buspirone impaired retention in the inhibitory avoidance task: involvement of amygdala 5-HT1A receptors. European Journal of Neuroscience 11 (1999) 1491-1500
83. Liy-Salmeron, G., Meneses, A., 2007. 5-HT1-7 receptors during autoshaping short- and long-term memory: intrahippocampal manipulations. Brain Research, in press, doi:10.1016/j.brainres.2007.02.007.
84. Luna-Munguia H., Manuel-Apolinar L., Rocha L., and Meneses A. 5-HT1A receptor expression during memory formation. Psychopharmacology (Berlin) 181 (2005) 309-318
85. Luttgen M., Elvander E., Madjid N., and Ogren S.O. Analysis of the role of 5-HT1A receptors in spatial and aversive learning in the rat. Neuropharmacology 48 (2005) 830-852
86. Lynch M.A. Long-term potentiation and memory. Physiological Reviews 84 (2004) 87-196
87. 1A receptor blockade facilitates aversive learning in mice: interactions with cholinergic and glutamatergic mechanisms. Journal of Pharmacology and Experimental Therapeutics 316 (2006) 581-591
88. Mahgoub M.A., Sara Y., Kavalali E.T., and Monteggia L.M. Reciprocal interaction of serotonin and neuronal activity in regulation of cAMP-responsive element-dependent gene expression. Journal of Pharmacology and Experimental Therapeutics 317 (2006) 88-96
89. Manuel-Apolinar L., and Meneses A. 8-OH-DPAT facilitated memory consolidation and increased hippocampal and cortical cAMP production. Behavioural Brain Research 148 (2004) 179-184
90. Manuel-Apolinar L., Rocha L., Pascoe D., Castillo E., Castillo C., and Meneses A. Modifications of 5-HT4 receptor expression in rat brain during memory consolidation. Brain Research 1042 (2005) 73-81
91. Markstein R., Hoyer D., and Engel G. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus. Naunyn Schmiedeberg's Archives of Pharmacology 333 (1986) 335-341
92. Markstein R., Matsumoto M., Kohler C., Togashi H., Yoshioka M., and Hoyer D. Pharmacological characterization of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus. Naunyn Schmiedeberg's Archives of Pharmacology 359 (1999) 454-459
93. 1A receptors show constitutive activity. Molecular Pharmacology 71 (2007) 638-643
94. McGaugh J.L. Dissociating learning and performance: drug and hormone enhancement of memory storage. Brain Research Bulletin 23 (1989) 339-345
95. Meeter M., Talamini L., Schmitt J.A., and Riedel W.J. Effects of 5-HT on memory and the hippocampus: model and data. Neuropsychopharmacology 31 (2006) 712-720
96. Mello e Souza T., Rodrigues C., Souza M.M., Vinade E., Coitinho A., Choi H., and Izquierdo I. Involvement of the serotonergic type 1A (5-HT1A) receptor in the agranular insular cortex in the consolidation of memory for inhibitory avoidance in rats. Behavioural Pharmacology 12 (2001) 349-353
97. Meltzer C.C., Smith G., Dekosky S.T., Pollock B.G., Mathis C.A., Moore R.Y., Kupfer D.J., and Reynolds C.F. Serotonin in aging, late-life depression and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology 18 (1998) 407-430
98. Meltzer H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21 (1999) 106-115
99. Meltzer H.Y., Li Z., Kaneda Y., and Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 (2003) 1159-1172
100. 1A receptor agonists induce anterograde amnesia in mice. European Journal of Pharmacology 236 (1993) 177-182
101. Meneses A. 5-HT system and cognition. Neuroscience and Biobehavioral Reviews 23 (1999) 1111-1125
102. 7 receptor subtypes function on a Pavlovian/instrumental autoshaped memory. Learning & Memory 10 (2003) 363-372
103. 7 receptor antagonists SB-269970 and DR 4004 in autoshaping Pavlovian/instrumental learning task. Behavioural Brain Research 155 (2004) 275-282
104. Meneses A. Are serotonin1-7 receptors modulating short- and long-term memory?. Neurobiology of Learning and Memory 87 (2007) 561-572
105. Meneses A., and Hong E. Effects of serotonergic compounds on associative learning. Proceedings of the Western Pharmacology Society 34 (1991) 461-464
106. Meneses A., and Hong E. Modification of 8-OH-DPAT effects on learning by manipulation of the assay conditions. Behavioral and Neural Biology 61 (1994) 29-35
107. Meneses A., and Hong E. Mechanisms of action of 8-OH-DPAT on learning and memory. Pharmacology Biochemistry and Behavior 49 (1994) 1083-1086
108. 1A receptors in acquisition, consolidation and retrieval of learning. CNS Drug Review 3 (1997) 68-82
109. 1A receptors modulate the consolidation of learning in normal and cognitively impaired rats. Neurobiology of Learning and Memory 71 (1999) 207-218
110. 7 receptors agonists in short- (STM) and long-term memory (LTM). Society for Neuroscience Meeting Abstract 666.21.
111. 7 receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation. Behavioural Brain Research 121 (1999) 21-28
112. Meneses A., Manuel-Apolinar L., Rocha L., Castillo E., and Castillo C. Expression of the 5-HT receptors in rat brain during memory consolidation. Behavioural Brain Research 152 (2004) 425-436
113. 1A receptors by systemic or medial septum injection induces anxiogenic-like effects and facilitates acquisition of a spatial discrimination task in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 23 (1999) 1113-1133
114. Middlemiss D.N., and Tricklebank M.D. Centrally active 5-HT receptor agonists and antagonists. Neuroscience and Biobehavioral Reviews 16 (1992) 75-82 (Review)
115. Millan M.J. Improving the treatment of schizophrenia: focus on serotonin (5-HT1A) receptors. Journal of Pharmacology and Experimental Therapeutics 295 (2000) 853-861
116. Millan M.J., Hjorth S., Samanin R., Schreiber R., Jaffard R., De Ladonchamps B., Veiga S., Goument B., Peglion J.L., Spedding M., and Brocco M. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties. Journal of Pharmacology and Experimental Therapeutics 282 (1997) 148-161
117. Millan M.J., Gobert A., Roux S., Porsolt R., Meneses A., Carli M., Di Cara B., Jaffard R., Rivet J.M., Lestage P., Mocaer E., Peglion J.L., and Dekeyne A. The serotonin1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis. Journal of Pharmacology and Experimental Therapeutics 311 (2004) 190-203
118. Misane I., and Ögren S.O. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT. Neuropsychopharmacology 22 (2000) 168-190
119. 1A antagonists WAY 100635 and NAD-299 attenuate the impairment of passive avoidance caused by scopolamine in the rat. Neuropsychopharmacology 28 (2003) 253-264
120. Molodtsova G.F., and Ilyuchenok R.Y. The pre- and postsynaptic mechanisms of the involvement of the serotonin of the amygdaloid body in the reproduction of the conditioned passive avoidance reaction in rats. Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I P Pavlova 48 (1998) 464-470
121. 1A) receptor-mediated learning deficit in rats. Neuropsychopharmacology 29 (2004) 2216-2224
122. Muller N.G., and Knight R.T. The functional neuroanatomy of working memory: contributions of human brain lesion studies. Neuroscience 139 (2006) 51-58
123. Negus S.S. Some implications of receptor theory for in vivo assessment of agonists, antagonists and inverse agonists. Biochemical Pharmacology 71 (2006) 1663-1670
124. 1A receptors: a [35S] GTPgammaS binding study. European Journal of Pharmacology 355 (1998) 245-256
125. 1A) receptors. Neuropsychopharmacology 18 (1998) 395-398
126. Ogren S.O. Evidence for a role of brain serotonergic neurotransmission in avoidance learning. Acta Physiologica Scandinavica Supplement 544 (1985) 1-71
127. Pache D.M., Sewell R.D., and Spencer P.S. Detecting drug effects on short-term memory function using a combined delayed matching and non-matching to position task. Journal of Pharmacological and Toxicological Methods 41 (1999) 135-141
128. Pache D.M., Fernandez-Perez S., and Sewell R.D. Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task. European Journal of Pharmacology 477 (2003) 205-211
129. 1A and 5-HT1B receptor knockout mice. Behavioural Brain Research 141 (2003) 137-145
130. Perez-Garcia G., and Meneses A. Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task. Pharmacology Biochemistry and Behavior 81 (2005) 673-682
131. Perez-Garcia G.S., and Meneses A. Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Behavioural Brain Research 163 (2005) 136-140
132. Perez-Garcia G., Gonzalez-Espinosa C., and Meneses A. An mRNA expression analysis of stimulation and blockade of 5-HT7 receptors during memory consolidation. Behavioural Brain Research 169 (2006) 83-92
133. Perry K.W., and Fuller R.W. Determination of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin by liquid chromatography with electrochemical detection. Biochemical Pharmacology 38 (1989) 3169-3173
134. 1A receptor antagonist WAY 100635 improves rats performance in different models of amnesia evaluated by the object recognition task. Brain Research 983 (2003) 215-222
135. 1A receptor and recognition memory: possible modulation of its behavioral effects by the nitrergic system. Behavioural Brain Research 159 (2005) 287-293
136. Porter R.J., Lunn R.S., and O'Brien J.T. Effects of acute tryptophan depletion on cognitive function in Alzheimer's disease and in the healthy elderly. Psychological Medicine 33 (2003) 41-49
137. Prado-Alcala R.A., Ruiloba M.I., Rubio L., Solana-Figueroa R., Medina C., Salado-Castillo R., and Quirarte G.L. Regional infusions of serotonin into the striatum and memory consolidation. Synapse 47 (2003) 169-175
138. 1A) receptor antagonist in rat brain. Journal of Pharmacology and Experimental Therapeutics 265 (1993) 739-744
139. Pucadyil T.J., and Chattopadhyay A. Role of cholesterol in the function and organization of G-protein coupled receptors. Progress in Lipid Research 45 (2006) 295-333
140. 1A serotonin antagonist 1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine with reduced alpha 1-adrenergic affinity. Journal of Medicinal Chemistry 34 (1991) 2633-2638
141. Raymond J.R., Mukhin Y.V., Gelasco A., Turner J., Collinsworth G., Gettys T.W., Grewal J.S., and Garnovskaya M.N. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacology & Therapeutics 92 (2001) 179-212
142. Rescorla R.A. Pavlovian conditioning and its proper control procedures. Psychological Review 74 (1967) 71-80
143. Riad M., Watkins K.C., Doucet E., Hamon M., and Descarries L. Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). Journal of Neuroscience 21 (2001) 8378-8386
144. 1A receptor agonist and muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior. Psychopharmacology 122 (1995) 137-146
145. 2A receptor in vivo. Psychopharmacology (Berlin) 184 (2006) 173-181
146. 2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task. Journal of Psychopharmacology 12 (1998) 177-185
147. 1A agonist 8-OH-DPAT: a case of gone, but not forgotten. Behavioral Neuroscience 118 (2004) 248-252
148. Santucci A.C., and Haroutunian V. Pharmacological and transgenic animal models of Alzheimer's disease. In: Charney D.S., and Nestler E.J. (Eds). Neurobiology of Mental Illness. second ed (2004), Oxford University press, New York 791-806
149. Santucci A.C., and Shaw C. Peripheral 8-OH-DPAT and scopolamine infused into the frontal cortex produce passive avoidance retention impairments in rats. Neurobiology of Learning and Memory 79 (2003) 136-141
150. Sambeth, A., Blokland, A., Harmer, C.J., Kilkens, T.O., Nathan, P.J., Porter, R.J., Schmitt, J.A., Scholtissen, B., Sobczak, S., Young, A.H., Riedel, W.J., 2007. Sex differences in the effect of acute tryptophan depletion on declarative episodic memory: A pooled analysis of nine studies. Neuroscience and Biobehavioural Reviews January 15 [Epub ahead of print].
151. 1A receptors. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 1473-1476
152. 6 receptor stimulation in antidepressant drug action and neuronal plasticity. Journal of Pharmacology Science 101 (2006) 62
153. 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. Journal of Experimental Pharmacology and Therapeutics 314 (2005) 1274-1289
154. Schiapparelli L., Del Rio J., and Frechilla D. Serotonin 5-HT receptor blockade enhances Ca(2+)/calmodulin-dependent protein kinase II function and membrane expression of AMPA receptor subunits in the rat hippocampus: implications for memory formation. Journal of Neurochemistry 94 (2005) 884-895
155. 1A receptor blockade on passive avoidance and object recognition performance: correlation with AMPA receptor subunit expression in rat hippocampus. Neuropharmacology 50 (2006) 897-907
156. Schmitt J.A.J., Winger M., Ramaekers J.G., Evers E.A.T., and Riedel W.J. Serotonin and human cognitive performance. Current Pharmaceutical Design 12 (2006) 2473-2486 (Review)
157. 1A receptor blockade is not associated with increased activity of the central nucleus of the amygdala. Learning & Memory 10 (2003) 394-400
158. Sirviö J., Riekkinen P., Jäkälä P., and Riekkinen P.J. Experimental studies on the role of serotonin in cognition. Progress in Neurobiology 43 (1994) 363-379
159. 1A receptor agents using a composite pharmacophore analysis and chemical database screening. Naunyn Schmiedeberg's Archives of Pharmacology 343 (1991) 109-116
160. Sloan H.L., Dobrossy M., and Dunnett S.B. Hippocampal lesions impair performance on a conditional delayed matching and non-matching to position task in the rat. Behavioural Brain Research 171 (2006) 240-250
161. Sloan H.L., Good M., and Dunnett S.B. Double dissociation between hippocampal and prefrontal lesions on an operant delayed matching task and a water maze reference memory task. Behavioural Brain Research 171 (2006) 116-126
162. Stanhope K.J., McLenachan A.P., and Dourish C.T. Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists. Psychopharmacology (Berlin) 122 (1995) 268-280 (Erratum in: Psychopharmacology (Berlin) 1997;129:398)
163. Steckler T., and Sahgal A. The role of serotonergic-cholinergic interactions in the mediation of cognitive behavior. Behavioural Brain Research 67 (1995) 165-199
164. 3 receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse 38 (2000) 328-337
165. 1A receptors in classical fear conditioning in C57BL/6J mice. Journal of Neuroscience 20 (2000) 8515-8527
166. 1A receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit. Psychopharmacology (Berlin) 181 (2005) 134-144
167. 1A receptor agonist flesinoxan: comparison with the benzodiazepine receptor agonist diazepam. Neuropsychopharmacology 28 (2003) 664-674
168. 2a binding in rat brain. Brain Research 975 (2003) 167-178
169. 1A, and alpha-adrenoceptor binding in hippocampus. Hippocampus 17 (2006) 68-77
170. Vanover K.E., and Barrett J.E. An automated learning and memory model in mice: pharmacological and behavioral evaluation of an autoshaped response. Behavioural Pharmacology 9 (1998) 273-283
171. Wang H., Hu Y., and Tsien J.Z. Molecular and systems mechanisms of memory consolidation and storage. Progress in Neurobiology 79 (2006) 123-135
172. 1A receptor agonist 8-OH-DPAT on spatial short-term working memory in rats. Behavioural Brain Research 84 (1997) 247-258
173. Welsh S.E., Kachelries W.J., Romano A.G., Simansky K.J., and Harvey J.A. Effects of LSD, ritanserin, 8-OH-DPAT, and lisuride on classical conditioning in the rabbit. Pharmacology Biochemistry and Behavior 59 (1998) 469-475
174. 1A receptor agonists disrupt learning and performance in rats. Journal of Pharmacology and Experimental Therapeutics 288 (1999) 335-347
175. 1A receptors in memory. Pharmacology Biochemistry and Behavior 27 (1987) 625-628
176. Wolff M., Benhassine N., Costet P., Segu L., and Buhot M.C. Interaction between the nature of the information and the cognitive requirement of the task in problem solving in mice. Cognitive Brain Research 21 (2004) 289-300
177. 1A receptor gene deletion in spatial learning abilities in mice. Brain Research-Molecular Brain Research 130 (2004) 39-48
178. 1A receptors on human explicit memory. American Journal of Psychiatry 160 (2003) 334-340